|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$72,557
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-04
|
$1,316,888
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Using zebrafish to study the role of six1a/b and microRNA-30a in rhabdomyosarcoma (RMS) initiation and progression
|
5R21CA201809-02
|
$202,928
|
FORD, HEIDE
|
UNIVERSITY OF COLORADO DENVER
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-02
|
$37,644
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$27,615
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-04
|
$768,950
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
2P30CA046934-29
|
$3,880,607
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S1
|
$3,780
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
University of Colorado Cancer Center Support Grant
|
3P30CA046934-29S2
|
$104,106
|
THEODORESCU, DAN
|
UNIVERSITY OF COLORADO DENVER
|
|
Underlying Mechanisms in Angiosarcoma
|
5R01CA197943-03
|
$352,275
|
IRUELA-ARISPE, M
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
1U54CA221208-01
|
$731,876
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-04
|
$1
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-02
|
$359,138
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
|
5R01CA181125-04
|
$224,100
|
PEARCE, ERIKA
|
INSTITUT FUR IMMUNBIOLOGIE/EPIGENETIK
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$137,137
|
Helman, Lee
|
CCR (NCI)
|
|
Training in Tumor Virology
|
2T32CA115299-11
|
$369,654
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Training In Tumor Virology
|
3T32CA115299-10S1
|
$3,684
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Thrombocytes in Cancer Immunity
|
5R01CA188419-03
|
$387,236
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Three-dimensional, mechanically tunable scaffold systems to model osteosarcoma heterogeneity and therapeutic response
|
5F31CA213994-02
|
$44,044
|
MOLINA, ERIC
|
RICE UNIVERSITY
|
|
Three-dimensional Model of Human Ewing Sarcoma
|
5R01CA180279-04
|
$322,736
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$719,531
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
1U54CA221204-01
|
$670,280
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-03
|
$2,373,000
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Johns Hopkins Physical Sciences Oncology Center
|
5U54CA210173-02
|
$2,118,358
|
WIRTZ, DENIS
|
JOHNS HOPKINS UNIVERSITY
|
|
The histone demethylase KDM3A upregulates MCAM to promote Ewing Sarcoma metastasis
|
5F31CA203053-02
|
$13,205
|
SECHLER, MARYBETH
|
UNIVERSITY OF COLORADO DENVER
|
|
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
|
1U24CA220245-01
|
$592,709
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
The CARMA3/Bcl10/MALT1 signalosome in osteosarcoma metastasis
|
5F30CA196095-02
|
$49,044
|
MCAULEY, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$972,309
|
Schrump, David
|
CCR (NCI)
|
|
TGIB Surgical Consultative Services
|
ZID BC 011541
|
$1,852,017
|
Schrump, David
|
CCR (NCI)
|
|
Testicular effects of modern chemotherapy regimens in osteosarcoma survivors
|
5R01CA175216-02
|
$644,375
|
SHNORHAVORIAN, MARGARETT
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Targeting vismodegib-resistant tumors using BH3 mimetics
|
5R01CA196851-02
|
$346,985
|
KIM, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
|
1R21CA218790-01
|
$208,637
|
HUANG, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-04
|
$435,560
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
1R01CA210911-01A1
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Targeting of Genes in the Mammalian Genome
|
5R01CA210165-42
|
$468,711
|
CAPECCHI, MARIO
|
UNIVERSITY OF UTAH
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-03
|
$377,438
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting insulin receptor splicing for treatment of rhabdomyosarcoma
|
5R21CA195324-02
|
$164,349
|
CHANDLER, DAWN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
|
ZIA BC 010999
|
$511,155
|
Khan, Javed
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|